The current pandemic caused by SARS‐CoV‐2 virus infection is known as Covid‐19
(coronavirus disease 2019). This disease can be asymptomatic or can affect multiple organ …

ABSTRACT C‐reactive protein (CRP) plays a role in the pathogenesis of cardiovascular
disease. It is a marker and predictor of cardiovascular disease. CRP possesses numerous …

Many patients with hypertension require≥ 3 agents to achieve target blood pressure (BP).
The efficacy/safety of the dual combinations of valsartan (Val)/hydrochlorothiazide (HCTZ) …

Increased levels of high-sensitivity C-reactive protein (hsCRP) are associated with incident
hypertension as well as cardiovascular events, and angiotensin II is a potent …

Objective Peripheral edema is considered to be a common and annoying adverse effect of
calcium channel blockers (CCBs). It has been thought to occur secondary to arteriolar …

In this randomized, double‐blind, multicenter study, patients whose blood pressure (BP) was
uncontrolled by monotherapy were switched directly to amlodipine/valsartan 5/160 mg (n …

Although effective control of blood pressure (BP) reduces the risk of cardiovascular events in
patients with hypertension, BP control rates among treated patients in actual clinical practice …

Combination therapy of hypertension with separate agents or a fixed-dose combination pill
offers the potential to lower blood pressure more quickly, obtain target blood pressure, and …

Valsartan is a nonpeptide angiotensin receptor antagonist that selectively blocks the binding
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …

Calcium antagonists have been shown to be superior over other antihypertensive drugs to
prevent stroke. Because this cannot be fully attributed to blood pressure lowering effects …